Mathilde T. Orbaek

Copenhagen, 2100, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Biomarkers of Lyme neuroborreliosis: a systematic review.

Biomarkers of Lyme neuroborreliosis: a systematic review.

Journal: Infection

Published: May 09, 2026

Evaluating the Diagnostic Accuracy of Point-of-Care CXCL13 Measurements for Lyme Neuroborreliosis.

Evaluating the Diagnostic Accuracy of Point-of-Care CXCL13 Measurements for Lyme Neuroborreliosis.

Journal: Diagnostics (Basel, Switzerland)

Published: March 06, 2026

64Cu-DOTATATE-PET/CT in Neuroborreliosis Shows Increased Tracer Uptake in Dorsal Root and Paravertebral Ganglia.

64Cu-DOTATATE-PET/CT in Neuroborreliosis Shows Increased Tracer Uptake in Dorsal Root and Paravertebral Ganglia.

Journal: Diagnostics (Basel, Switzerland)

Published: December 16, 2025

Prevalence of Borrelia miyamotoi and Neoehrlichia mikurensis in a cohort of tick-exposed individuals and population controls in Denmark 2002-2021.

Prevalence of Borrelia miyamotoi and Neoehrlichia mikurensis in a cohort of tick-exposed individuals and population controls in Denmark 2002-2021.

Journal: Ticks and tick-borne diseases

Published: July 24, 2025

Borrelia afzelii-associated seronegative Lyme neuroborreliosis in an immunocompromised patient.

Borrelia afzelii-associated seronegative Lyme neuroborreliosis in an immunocompromised patient.

Journal: Diagnostic microbiology and infectious disease

Published: May 12, 2025

Findings on Magnetic Resonance Imaging in Neuroborreliosis-A Nationwide Cohort Study.

Findings on Magnetic Resonance Imaging in Neuroborreliosis-A Nationwide Cohort Study.

Journal: European journal of neurology

Published: January 30, 2025

Plasma levels of the neuron damage markers brain-derived tau and glial fibrillary acidic protein in Lyme neuroborreliosis: A longitudinal study.

Plasma levels of the neuron damage markers brain-derived tau and glial fibrillary acidic protein in Lyme neuroborreliosis: A longitudinal study.

Journal: Ticks and tick-borne diseases

Published: August 18, 2024

Neoehrlichia mikurensis is uncommon in rheumatological patients receiving tumour necrosis factor inhibitors and in blood donors: a retrospective cohort study.

Neoehrlichia mikurensis is uncommon in rheumatological patients receiving tumour necrosis factor inhibitors and in blood donors: a retrospective cohort study.

Journal: RMD open

Published: August 29, 2023

Cerebrospinal fluid levels of the macrophage-specific biomarker sCD163 are diagnostic for Lyme neuroborreliosis: An observational cohort study.

Cerebrospinal fluid levels of the macrophage-specific biomarker sCD163 are diagnostic for Lyme neuroborreliosis: An observational cohort study.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: February 05, 2023

Plasma neurofilament light significantly decreases following treatment in Lyme neuroborreliosis and is not associated with persistent symptoms.

Plasma neurofilament light significantly decreases following treatment in Lyme neuroborreliosis and is not associated with persistent symptoms.

Journal: European journal of neurology

Published: October 28, 2022

Exploration of the induced cytokine responses in European Lyme neuroborreliosis: A longitudinal cohort study.

Exploration of the induced cytokine responses in European Lyme neuroborreliosis: A longitudinal cohort study.

Journal: Ticks and tick-borne diseases

Published: July 06, 2022

Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis.

Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis.

Journal: Journal of central nervous system disease

Published: December 16, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026